IL178120A0 - Therapeutic combination for treatment of alzheimers disease - Google Patents
Therapeutic combination for treatment of alzheimers diseaseInfo
- Publication number
- IL178120A0 IL178120A0 IL178120A IL17812006A IL178120A0 IL 178120 A0 IL178120 A0 IL 178120A0 IL 178120 A IL178120 A IL 178120A IL 17812006 A IL17812006 A IL 17812006A IL 178120 A0 IL178120 A0 IL 178120A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- therapeutic combination
- alzheimers disease
- alzheimers
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56214104P | 2004-04-14 | 2004-04-14 | |
| PCT/IB2005/000923 WO2005099823A1 (en) | 2004-04-14 | 2005-04-04 | Therapeutic combination for treatment of alzheimers disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL178120A0 true IL178120A0 (en) | 2006-12-31 |
Family
ID=34963723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL178120A IL178120A0 (en) | 2004-04-14 | 2006-09-14 | Therapeutic combination for treatment of alzheimers disease |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1737539A1 (zh) |
| JP (1) | JP2007532624A (zh) |
| KR (1) | KR20060133008A (zh) |
| CN (1) | CN1960781A (zh) |
| AU (1) | AU2005232447A1 (zh) |
| BR (1) | BRPI0509881A (zh) |
| CA (1) | CA2562069A1 (zh) |
| IL (1) | IL178120A0 (zh) |
| MX (1) | MXPA06011969A (zh) |
| NO (1) | NO20065196L (zh) |
| RU (1) | RU2006136361A (zh) |
| TW (1) | TW200533341A (zh) |
| WO (1) | WO2005099823A1 (zh) |
| ZA (1) | ZA200608239B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI432195B (zh) * | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
| PT3413870T (pt) * | 2016-02-11 | 2021-09-10 | Sigmathera Sas | Igmesina para utilização no tratamento de doença de alzheimer |
| CN114007609A (zh) * | 2019-06-14 | 2022-02-01 | 约书亚·O·阿蒂巴 | 用于蛋白质感染的三重药物组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
| MXPA04009535A (es) * | 2002-04-02 | 2005-01-25 | Janssen Pharmaceutica Nv | Terapia con estatina para mejorar el mantenimiento cognoscitivo. |
| AU2003298514A1 (en) * | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
| AU2003292936A1 (en) * | 2002-12-24 | 2004-07-22 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| EP1603548A4 (en) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS |
| EP1620124A2 (en) * | 2003-03-19 | 2006-02-01 | Ares Trading S.A. | Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders |
| US20050090449A1 (en) * | 2003-05-13 | 2005-04-28 | Boehringer Ingelheim International Gmbh | Novel statine derivatives for the treatment of Alzheimer's disease |
-
2005
- 2005-04-04 JP JP2007507862A patent/JP2007532624A/ja not_active Withdrawn
- 2005-04-04 KR KR1020067021174A patent/KR20060133008A/ko not_active Application Discontinuation
- 2005-04-04 EP EP05718393A patent/EP1737539A1/en not_active Withdrawn
- 2005-04-04 RU RU2006136361/15A patent/RU2006136361A/ru not_active Application Discontinuation
- 2005-04-04 MX MXPA06011969A patent/MXPA06011969A/es unknown
- 2005-04-04 CN CNA2005800173902A patent/CN1960781A/zh active Pending
- 2005-04-04 WO PCT/IB2005/000923 patent/WO2005099823A1/en active Application Filing
- 2005-04-04 CA CA002562069A patent/CA2562069A1/en not_active Abandoned
- 2005-04-04 BR BRPI0509881-5A patent/BRPI0509881A/pt not_active IP Right Cessation
- 2005-04-04 AU AU2005232447A patent/AU2005232447A1/en not_active Abandoned
- 2005-04-13 TW TW094111657A patent/TW200533341A/zh unknown
-
2006
- 2006-09-14 IL IL178120A patent/IL178120A0/en unknown
- 2006-10-03 ZA ZA200608239A patent/ZA200608239B/en unknown
- 2006-11-13 NO NO20065196A patent/NO20065196L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0509881A (pt) | 2007-10-16 |
| ZA200608239B (en) | 2008-06-25 |
| AU2005232447A1 (en) | 2005-10-27 |
| NO20065196L (no) | 2007-01-03 |
| TW200533341A (en) | 2005-10-16 |
| CA2562069A1 (en) | 2005-10-27 |
| KR20060133008A (ko) | 2006-12-22 |
| JP2007532624A (ja) | 2007-11-15 |
| RU2006136361A (ru) | 2008-04-20 |
| MXPA06011969A (es) | 2006-12-15 |
| EP1737539A1 (en) | 2007-01-03 |
| CN1960781A (zh) | 2007-05-09 |
| WO2005099823A1 (en) | 2005-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1207821A1 (zh) | 用於治療視網膜變性病的改良模式 | |
| IL227841A0 (en) | Dihydropyridinones for the treatment of cancer | |
| AP2006003671A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| AP2006003669A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| PL2422786T3 (pl) | Nowe kombinacje środków leczniczych do leczenia chorób dróg oddechowych | |
| IL178815A0 (en) | The treatment of respiratory disease | |
| GB0410399D0 (en) | The treatment of respiratory disease | |
| EP1924286A4 (en) | PROPHYLACTIC AND / OR THERAPEUTIC METHOD FOR THE TREATMENT OF AUTOIMMUNE DISEASES | |
| IL178120A0 (en) | Therapeutic combination for treatment of alzheimers disease | |
| GB0400802D0 (en) | Compounds for the treatment of disease | |
| EP1846013A4 (en) | TREATMENT OF SKIN DISEASES | |
| GB0428218D0 (en) | Medicament for Treatment of Inflammatory Diseases | |
| GB0425854D0 (en) | Therapeutic treatment | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| AP2006003728A0 (en) | Compounds for treatment of diseases | |
| GB0415352D0 (en) | Compounds for the treatment of disease | |
| GB0408752D0 (en) | Therapeutic treatment | |
| GB0407710D0 (en) | Treatment of diseases | |
| GB0425073D0 (en) | Compounds for the treatment of diseases | |
| GB0420867D0 (en) | Compounds for the treatment of diseases | |
| GB0520152D0 (en) | Treatment of respiratory disease | |
| GB0405805D0 (en) | Therapeutic treatment for tinnitus | |
| GB0425064D0 (en) | Compounds useful for the treatment of diseases | |
| AP2006003743A0 (en) | Compounds useful for the treatment of diseases | |
| GB0404339D0 (en) | Therapeutic treatment |